Marco Allinovi

2.0k total citations
63 papers, 809 citations indexed

About

Marco Allinovi is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marco Allinovi has authored 63 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Nephrology, 25 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marco Allinovi's work include Amyloidosis: Diagnosis, Treatment, Outcomes (20 papers), Renal Diseases and Glomerulopathies (18 papers) and Complement system in diseases (10 papers). Marco Allinovi is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (20 papers), Renal Diseases and Glomerulopathies (18 papers) and Complement system in diseases (10 papers). Marco Allinovi collaborates with scholars based in Italy, United Kingdom and United States. Marco Allinovi's co-authors include Wesley Hayes, Paola Romagnani, Maria Lucia Angelotti, Francesca Becherucci, Marco Delsante, Federico Perfetto, Francesco Cappelli, Moin A. Saleem, Leonardo Caroti and Nantheera Anantrasirichai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of the American Society of Nephrology.

In The Last Decade

Marco Allinovi

58 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Allinovi Italy 16 322 231 223 176 139 63 809
P. Cluzel France 14 76 0.2× 651 2.8× 61 0.3× 153 0.9× 107 0.8× 29 1.0k
Jens‐Peter Schenk Germany 20 77 0.2× 405 1.8× 275 1.2× 43 0.2× 20 0.1× 83 1.3k
Wataru Ishii Japan 18 50 0.2× 180 0.8× 209 0.9× 27 0.2× 101 0.7× 97 902
S. Morell‐Dubois France 19 85 0.3× 379 1.6× 250 1.1× 15 0.1× 308 2.2× 62 1.4k
Alessandra Della Rossa Italy 19 32 0.1× 425 1.8× 104 0.5× 64 0.4× 209 1.5× 59 1.3k
Phan Nguyen Australia 18 39 0.1× 363 1.6× 76 0.3× 37 0.2× 198 1.4× 68 910
Daniël Knockaert Belgium 9 84 0.3× 513 2.2× 86 0.4× 19 0.1× 41 0.3× 16 928
Alfred Koenigsrainer Germany 18 74 0.2× 232 1.0× 51 0.2× 46 0.3× 152 1.1× 53 1.5k
Hamit Küçük Türkiye 14 87 0.3× 141 0.6× 181 0.8× 8 0.0× 160 1.2× 51 635
Masahiro Hagiwara Japan 14 154 0.5× 143 0.6× 91 0.4× 8 0.0× 35 0.3× 53 546

Countries citing papers authored by Marco Allinovi

Since Specialization
Citations

This map shows the geographic impact of Marco Allinovi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Allinovi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Allinovi more than expected).

Fields of papers citing papers by Marco Allinovi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Allinovi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Allinovi. The network helps show where Marco Allinovi may publish in the future.

Co-authorship network of co-authors of Marco Allinovi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Allinovi. A scholar is included among the top collaborators of Marco Allinovi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Allinovi. Marco Allinovi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allinovi, Marco, Cinzia Finocchi, Leonardo Caroti, et al.. (2025). Urinary rituximab loss and rate of treatment failure in membranous nephropathy. Nephrology Dialysis Transplantation. 41(1). 92–101. 2 indexed citations
2.
Allinovi, Marco, et al.. (2025). The evolving spectrum of kidney amyloidosis: advances in diagnosis, typing and treatment. Nephrology Dialysis Transplantation. 40(10). 1826–1837.
3.
Raglianti, Valentina, Maria Lucia Angelotti, Letizia De Chiara, et al.. (2025). Anti-slit Antibodies against Podocin and Kirrel1 in Pediatric and Adult Podocytopathies. Journal of the American Society of Nephrology. 36(4). 702–705. 10 indexed citations
4.
Vargas-Brochero, Maria J., Marco Allinovi, Chiara Somma, et al.. (2025). Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index. Nephrology Dialysis Transplantation. 1 indexed citations
5.
Nardi, Giulia, Marco Allinovi, Gianmarco Lugli, et al.. (2024). Contrast-Induced Acute Kidney Injury in Patients with Heart Failure on Sodium–Glucose Cotransporter-2 Inhibitors Undergoing Radiocontrast Agent Invasive Procedures: A Propensity-Matched Analysis. Journal of Clinical Medicine. 13(7). 2041–2041. 5 indexed citations
6.
Allinovi, Marco, et al.. (2024). Monoclonal gammopathy is present in one fourth of patients undergoing renal biopsy but is pathogenic only in half of them. Journal of Nephrology. 38(2). 541–550. 2 indexed citations
7.
Teisseyre, Maxime, Marco Allinovi, Vincent Audard, et al.. (2024). Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies. Kidney International Reports. 10(3). 753–761. 8 indexed citations
8.
Allinovi, Marco, Francesco Sessa, Gianluca Villa, et al.. (2023). Novel Biomarkers for Early Detection of Acute Kidney Injury and Prediction of Long-Term Kidney Function Decline after Partial Nephrectomy. Biomedicines. 11(4). 1046–1046. 12 indexed citations
9.
Smorti, Martina, Lucia Ponti, Alessia Argirò, et al.. (2023). Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis. Frontiers in Psychology. 13. 1066224–1066224. 8 indexed citations
10.
Yang, Tianqi, Nantheera Anantrasirichai, Oktay Karakuş, Marco Allinovi, & Alin Achim. (2023). A Semi-Supervised Learning Approach for B-Line Detection in Lung Ultrasound Images. 1 indexed citations
11.
Argirò, Alessia, Costanza Bürgisser, Francesco Fattirolli, et al.. (2023). Serial Changes in Cardiopulmonary Exercise Testing Parameters in Untreated Patients With Transthyretin Cardiac Amyloidosis. Canadian Journal of Cardiology. 40(3). 364–369. 3 indexed citations
12.
Maffini, Enrico, et al.. (2023). Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management. Frontiers in Pharmacology. 13. 1088031–1088031. 38 indexed citations
13.
Perfetto, Federico, Mattia Zampieri, Carlo Fumagalli, Marco Allinovi, & Francesco Cappelli. (2022). Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist. Internal and Emergency Medicine. 17(4). 957–969. 15 indexed citations
14.
Argirò, Alessia, Annamaria Del Franco, Marco Allinovi, et al.. (2022). Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not. Biomedicines. 10(11). 2888–2888. 9 indexed citations
15.
Perfetto, Federico, Mattia Zampieri, Giulia Bandini, et al.. (2022). Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease. Biomedicines. 10(12). 3226–3226. 6 indexed citations
16.
Zampieri, Mattia, Marco Allinovi, Iacopo Olivotto, et al.. (2021). Ventricular tachyarrhythmias and sudden cardiac death in light‐chain amyloidosis: a clash of cardio‐toxicities?. British Journal of Haematology. 193(4). e27–e31. 5 indexed citations
17.
Cirillo, Luigi, Chiara Somma, Marco Allinovi, et al.. (2021). Ferric carboxymaltose vs. ferrous sulfate for the treatment of anemia in advanced chronic kidney disease: an observational retrospective study and cost analysis. Scientific Reports. 11(1). 7463–7463. 7 indexed citations
18.
Antonelli, Alessandro, Marco Allinovi, Andrea Cocci, et al.. (2018). The Predictive Role of Biomarkers for the Detection of Acute Kidney Injury After Partial or Radical Nephrectomy: A Systematic Review of the Literature. European Urology Focus. 6(2). 344–353. 31 indexed citations
19.
Allinovi, Marco, et al.. (2016). Finding covert fluid: methods for detecting volume overload in children on dialysis. Pediatric Nephrology. 31(12). 2327–2335. 28 indexed citations
20.
Manenti, Lucio, Augusto Vaglio, Umberto Maggiore, et al.. (2015). Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis. Clinical Journal of the American Society of Nephrology. 10(12). 2143–2151. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Cluzel Breakdown of academic impact, for papers by Jens‐Peter Schenk Breakdown of academic impact, for papers by Wataru Ishii Breakdown of academic impact, for papers by S. Morell‐Dubois Breakdown of academic impact, for papers by Alessandra Della Rossa Breakdown of academic impact, for papers by Phan Nguyen Breakdown of academic impact, for papers by Daniël Knockaert Breakdown of academic impact, for papers by Alfred Koenigsrainer Breakdown of academic impact, for papers by Hamit Küçük Breakdown of academic impact, for papers by Masahiro Hagiwara
Rankless by CCL
2026